Back to Search
EDWARD NEUWELT, MD
MD
General Acute Care Hospital
NPI: 1114022837Individual
Specialties, Licenses & Credentials
General Acute Care HospitalPrimary
General Acute Care Hospital
Code: 282N00000X
Research & Publications (20)
Ultrasmall superparamagnetic iron oxides (USPIOs): a future alternative magnetic resonance (MR) contrast agent for patients at risk for nephrogenic systemic fibrosis (NSF)?
PMID 18843256·Kidney Int·2009
5-case
Strategies to advance translational research into brain barriers.
PMID 18093565·Lancet Neurol·2008
6-review
The potential of ferumoxytol nanoparticle magnetic resonance imaging, perfusion, and angiography in central nervous system malignancy: a pilot study.
PMID 17415196·Neurosurgery·2007
8-other
Toxicity profile of delayed high dose sodium thiosulfate in children treated with carboplatin in conjunction with blood-brain-barrier disruption.
PMID 16086410·Pediatr Blood Cancer·2006
8-other
Imaging changes and cognitive outcome in primary CNS lymphoma after enhanced chemotherapy delivery.
PMID 15709122·AJNR Am J Neuroradiol·2005
8-other
Bone marrow chemoprotection without compromise of chemotherapy efficacy in a rat brain tumor model.
PMID 14752063·J Pharmacol Exp Ther·2004
7-preclinical
Imaging of iron oxide nanoparticles by MR and light microscopy in patients with malignant brain tumours.
PMID 15488022·Neuropathol Appl Neurobiol·2004
4-observational
Therapeutic efficacy of aortic administration of N-acetylcysteine as a chemoprotectant against bone marrow toxicity after intracarotid administration of alkylators, with or without glutathione depletion in a rat model.
PMID 11691805·Cancer Res·2001
7-preclinical
Efficacy and MRI of rituximab and methotrexate treatment in a nude rat model of CNS lymphoma.
PMID 19158414·Neuro Oncol·2009
7-preclinical
Cyclophosphamide enhances human tumor growth in nude rat xenografted tumor models.
PMID 19177203·Neoplasia·2009
7-preclinical
FAPP2 gene downregulation increases tumor cell sensitivity to Fas-induced apoptosis.
PMID 19341712·Biochem Biophys Res Commun·2009
8-other
Bevacizumab and carboplatin increase survival and asymptomatic tumor volume in a glioma model.
PMID 18772353·Neuro Oncol·2009
7-preclinical
Dynamic MRI using iron oxide nanoparticles to assess early vascular effects of antiangiogenic versus corticosteroid treatment in a glioma model.
PMID 19142191·J Cereb Blood Flow Metab·2009
4-observational
Blood-brain barrier disruption and intra-arterial methotrexate-based therapy for newly diagnosed primary CNS lymphoma: a multi-institutional experience.
PMID 19451444·J Clin Oncol·2009
4-observational
Cultured human endothelial cells expressing HIV-1 Vpu and Tat support the expansion of malignant B cells from primary central nervous system lymphoma.
PMID 18227216·Br J Ophthalmol·2008
8-other
N-acetylcysteine use to prevent contrast medium-induced nephropathy: premature phase III trials.
PMID 18295688·J Vasc Interv Radiol·2008
6-review
Primary CNS lymphoma with intraocular involvement: International PCNSL Collaborative Group Report.
PMID 18936428·Neurology·2008
4-observational
siRNA Down-regulation of the PATZ1 Gene in Human Glioma Cells Increases Their Sensitivity to Apoptotic Stimuli.
PMID 19081762·Cancer Ther·2008
8-other
Sodium thiosulfate administered six hours after cisplatin does not compromise antineuroblastoma activity.
PMID 18223229·Clin Cancer Res·2008
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3181 SW SAM JACKSON PARK RD, MAILCODE L603
PORTLAND, OR 97239 - Phone
- (503) 494-5626
Quick Facts
- NPI
- 1114022837
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile